U.S. flag

An official website of the United States government

NM_005359.6(SMAD4):c.1333C>T (p.Arg445Ter) AND Juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome

Germline classification:
Pathogenic (2 submissions)
Last evaluated:
Feb 9, 2024
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000023059.12

Allele description [Variation Report for NM_005359.6(SMAD4):c.1333C>T (p.Arg445Ter)]

NM_005359.6(SMAD4):c.1333C>T (p.Arg445Ter)

Gene:
SMAD4:SMAD family member 4 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
18q21.2
Genomic location:
Preferred name:
NM_005359.6(SMAD4):c.1333C>T (p.Arg445Ter)
HGVS:
  • NC_000018.10:g.51076662C>T
  • NG_013013.2:g.113623C>T
  • NM_005359.6:c.1333C>TMANE SELECT
  • NP_005350.1:p.Arg445Ter
  • NP_005350.1:p.Arg445Ter
  • LRG_318t1:c.1333C>T
  • LRG_318:g.113623C>T
  • LRG_318p1:p.Arg445Ter
  • NC_000018.9:g.48603032C>T
  • NM_005359.5:c.1333C>T
  • p.R445*
Protein change:
R445*; ARG445TER
Links:
OMIM: 600993.0014; dbSNP: rs377767360
NCBI 1000 Genomes Browser:
rs377767360
Molecular consequence:
  • NM_005359.6:c.1333C>T - nonsense - [Sequence Ontology: SO:0001587]

Condition(s)

Name:
Juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome (JPHT)
Synonyms:
JP/HHT SYNDROME; JUVENILE POLYPOSIS WITH HEREDITARY HEMORRHAGIC TELANGIECTASIA; POLYPOSIS, GENERALIZED JUVENILE, WITH PULMONARY ARTERIOVENOUS MALFORMATION; See all synonyms [MedGen]
Identifiers:
MONDO: MONDO:0008278; MedGen: C1832942; Orphanet: 2929; OMIM: 175050

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000044350OMIM
no assertion criteria provided
Pathogenic
(May 1, 2011)
germlineliterature only

PubMed (1)
[See all records that cite this PMID]

SCV004931948Myriad Genetics, Inc.
criteria provided, single submitter

(Myriad Autosomal Dominant, Autosomal Recessive and X-Linked Classification Criteria (2023))
Pathogenic
(Feb 9, 2024)
unknownclinical testing

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlinenot providednot providednot providednot providednot providednot providedliterature only
not providedunknownunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

SMAD4 mutation segregating in a family with juvenile polyposis, aortopathy, and mitral valve dysfunction.

Andrabi S, Bekheirnia MR, Robbins-Furman P, Lewis RA, Prior TW, Potocki L.

Am J Med Genet A. 2011 May;155A(5):1165-9. doi: 10.1002/ajmg.a.33968. Epub 2011 Apr 4.

PubMed [citation]
PMID:
21465659

Details of each submission

From OMIM, SCV000044350.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedliterature only PubMed (1)

Description

In 3 affected members of a family with a clinical variant of JPHT (175050), Andrabi et al. (2011) identified a heterozygous mutation in exon 10 of the SMAD4 gene, resulting in an arg445-to-ter (R445X) substitution. The clinical features in this family were unusual in that affected members had mitral valve prolapse, mitral valve regurgitation, and aortic dilatation in addition to gastrointestinal hamartomatous polyps; telangiectases were not reported. Andrabi et al. (2011) noted the role of SMAD4 in the TGF-beta-1 signaling pathway, suggesting overlap with other connective tissue disorders such as Marfan syndrome (154700) and Loeys-Dietz syndrome (see, e.g., 609192). The findings indicated that haploinsufficiency of SMAD4 may cause an aortopathy and mitral valve dysfunction.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlinenot providednot providednot providednot providednot providednot providednot providednot provided

From Myriad Genetics, Inc., SCV004931948.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided

Description

This variant is considered pathogenic. This variant creates a termination codon and is predicted to result in premature protein truncation.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1unknownunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Nov 3, 2024